Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 6/20 | 0.59 |
| ▸ | ARG1 | P05089 | 1/20 | 0.53 |
| ▸ | ARG2 | P78540 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 3/20 | 0.47 |
| ▸ | NOS1 | P29475 | 2/20 | 0.47 |
| ▸ | NOS3 | P29474 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM6 | O15303 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbocysteine SCHEMBL6762355 | 1.00 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL20854 | 1.00 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL9236855 | 1.00 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614508 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614507 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614516 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614546 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL15545269 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614495 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614544 | 0.98 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7024 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| US-20260125686-A1 | COMPOSITIONS AND METHODS FOR MODULATION OF CFTR | CYSTIC FIBROSIS FOUND (US) | 2026-05-07 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4736863-A1 | NOVEL MENTHOL-EUCALYPTUS OIL ANTITUSSIVE SPRAY AND USE THEREOF | Sino-Shine Biopharmaceutical Co., Ltd (CN) | 2026-05-06 | — | — | EP | claimed |
| US-20260091052-A1 | MICRORNA AND USES THEREOF IN PREVENTION AND/OR TREATMENT OF FIBROPLASIA MEDICAL SIGN AND/OR SYNDROME | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2026-04-02 | — | — | US | claimed |
| US-12533095-B1 | Airway mucus scoring system | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-27 | — | — | US | claimed |
| EP-4680248-A1 | PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM | Topelia Aust Limited (ACN 652 771 670) (AU) | 2026-01-21 | — | — | EP | claimed |
| US-20250332088-A1 | SUSTAINED RELEASE COMPOSITIONS | RUBICON RES PRIVATE LIMITED (IN) | 2025-10-30 | — | — | US | claimed |
| US-20250268841-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2025-08-28 | — | — | US | claimed |
| US-20250269005-A1 | METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT | TOPELIA AUST LIMITED (ACN 652 771 670) (AU) | 2025-08-28 | — | — | US | claimed |
| US-4411840-A | Process for the resolution of the racemate S-(carboxymethyl)-(RS)-cysteine (B) | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1983-10-25 | — | — | US | claimed |
| EP-0090087-A1 | Process for the production of S-(carboxymethyl)-R-cysteine and S-(carboxymethyl)-S-cysteine | Degussa Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | claimed |
| EP-0088998-A1 | Process for racemising optically active S-(carboxy-methyl) cysteine | Degussa Aktiengesellschaft (DE) | 1983-09-21 | — | — | EP | claimed |
| EP-0073054-A1 | Process for the resolution of the racemate (1RS,2SR)-2-amino-1-phenyl-propan-1-ol | Degussa Aktiengesellschaft (DE) | 1983-03-02 | — | — | EP | claimed |
| US-4369172-A | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | FOREST LABORATORIES INC. (US) | 1983-01-18 | — | — | US | claimed |
| US-4288433-A | THIOETHER AND A XANTHINE DERIVATIVE | L'OREAL (FR) | 1981-09-08 | — | — | US | claimed |
| US-4073898-A | Composition for reducing the oily appearance of the hair and skin | L'OREAL (FR) | 1978-02-14 | — | — | US | claimed |
| US-4071517-A | Soluble salts containing sulphur | DUFOUR CLAUDE | 1978-01-31 | — | — | US | claimed |
| US-RE29256-E | Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith | RECHERCHE PHARMACEUTIQUES ET SCIENTIFIQUES (FR) | 1977-06-07 | — | — | US | claimed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | claimed |